Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Erlotinib and Radiotherapy in Stage III Cutaneous SCC
NCT00369512Phase 2Completed
- Sponsor
- University of Alabama at Birmingham
- Start
- Aug 2006
- Primary completion
- Jan 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of erlotinib in cutaneous squamous cell carcinoma (cSCC), sponsored by University of Alabama at Birmingham. Started Aug 2006; status: completed.
02
Drugs
erlotinib
03
Conditions
cutaneous squamous cell carcinoma (cSCC)
Beyond the preview
Go deeper on NCT00369512.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00369512.